Constellation's Modelo Engine Is Stalled. At 10 Times Earnings, Who Has the Odds?

Constellation Brands' most important number is a small, negative one: beer shipments to distributors — the company's term, "depletions" — fell 0.3% in its latest quarter. For a decade, that number was the reason the stock traded like a growth company: Modelo Especial and Corona were the only reliable share-grabbers left in U.S. beer. Now the engine is idling, and the market has punished the stock accordingly, to roughly ten times forward earnings with a 3.3% dividend yield. One camp sees a broken growth story that the low multiple is finally admitting. The other sees a still-profitable cash cow whose misery is already priced. On October 6, after the market close, Constellation reports its fiscal second quarter, and that one depletion number will be the test.

The shared facts both sides sign

Set the date and the wager first. As of September 10, shares trade near $124, within a few dollars of their 52-week low of $120.25 and about 18% below where they sat four months ago. Market value is $21 billion, but there is $10.4 billion of net debt on top, so the whole enterprise is worth about $31.6 billion. The trailing price-to-earnings ratio is about 11.6; forward, it is roughly 10.2. The yield of 3.35% rests on a quarterly dividend of $1.03.

The quarter that just passed — fiscal Q1, ended May 31 — set the tone. Reported net sales fell 3% to $2.43 billion, but that drop is mostly an accounting artifact: Constellation sold off much of its mainstream wine and spirits last year, and organic net sales actually rose low-single digits. Beer, roughly 90% of profit, grew net sales about 2% to $2.28 billion on higher prices, and the portfolio was still the top dollar-share-gainer in U.S. tracked channels, adding 0.6 points of share. Comparable earnings per share came in at $3.43, up 7% year over year; reported EPS of $3.79 rose 31%, flattered by divestiture gains.

Here is the fact that bothers both camps: within that growing beer business, the brands that built the company are now shrinking. Modelo Especial depletions fell about 2%, Corona Extra fell more than 5%. Only the smaller labels — Pacifico up 21%, Victoria up 14%, Modelo Chelada up 6% — offset the declines. Management explained the softness plainly: inflation, a U.S. gas-price spike that ran above 50% during the quarter, and a Hispanic consumer base — roughly half of U.S. beer buyers — trading down under cost-of-living and immigration-related anxiety.

Round one: Is the demand hit cyclical or structural?

The bull's case is that this is a demand cycle, not a franchise break. Modelo Especial is still the top beer brand in U.S. dollar sales. Constellation is still gaining share even as the category shrinks, still winning distribution, still growing Pacifico and Victoria double digits. If the pain is inflation plus one sharp gas shock, the pitcher refills when the consumer's wallet does. Buy the business at ten times earnings while the market behaves as if Modelo's crown is gone, and a mere stabilization re-rates the stock toward its staples peers.

The bear's answer carries real weight: a share-gainer that is losing volume on its two flagship brands is a business whose growth engine is off, and its lower-income, Hispanic-skewed core is exactly the segment being squeezed hardest. If that consumer does not bounce back, "stable" beer means a permanent no-growth, mature-staples business — which is precisely what a ten-times multiple already pays for. The bear wins the point that nothing in the latest quarter proves the stall is temporary. But the bull wins this round on the score that matters: at ten times earnings, the market is already charging the full bear price. No growth is the default assumption now, not a risk the stock is ignoring.

Round two: Can the cash flow and the balance sheet carry the value story?

Both sides agree Constellation prints cash. In Q1 it generated $662 million of operating cash flow and $485 million of free cash flow; trailing free cash flow is about $1.8 billion. That cash covers the dividend and funded $324 million of buybacks in the quarter alone. The company targets comparable net leverage around 3.0 times, and at $10.4 billion of net debt against an $11-plus forward earnings base, that ratio is roughly in line.

The bear's counter is not solvency — it is what threatens the cash-flavored bull case from outside. The 25% tariff applied to Mexico and to imported canned beer, plus aluminum tariffs, directly raise the cost of the cans and imported cases that make up the core business. That is why guidance treats fiscal 2027 as a flat year: management expects beer revenue and organic wine-and-spirits revenue each to land between a 1% decline and a 1% gain, with comparable EPS held at $11.20 to $11.90. The bear can accept the cash and still argue the multiple is cheap because the tariff-driven cost burden is a persistent, not one-time, drag — and a growing one if escalations continue.

That is the bear's heaviest punch, and it is legitimate. But it is a margin question, not a survival question. Constellation's leverage is manageable, its free cash flow more than covers the dividend and buys back stock, and the divestitures have actually improved the quality of what remains. The bull wins this round on durability: this is a company that can fund its own flat path, which is what the price is asking it to do.

What the price demands

Now make both stories pay rent. At roughly ten times forward earnings, the market is not asking Constellation to grow. It is asking the company to stand still — hold beer roughly flat, hold comparable margins against tariffs, and keep the dividend and buybacks flowing — and to do none of the Modelo volume growth that used to justify a premium multiple. That is a low bar, and the evidence suggests the company can clear it while it lasts.

Compare the price to its peers to see the de-rating's scale. Constellation trades at about 11.6 times trailing earnings; Anheuser-Busch InBev sits near 16.4, Altria near 14.4, Diageo near 27.7. Even accounting for Constellation's heavier leverage and its now-stalled growth, the market has priced this franchise as the weakest of the group. The bull does not need a fantastic story to win here — only a slightly better one than the 10-times "no growth forever" bet the stock already embodies.

The ruling

The bear wins the business-growth debate: the Modelo/Corona engine is genuinely off, and nothing reported so far proves it comes back. But the stock call goes to the bull at this price. Ten times forward earnings, a 3.35% yield, roughly $1.8 billion of free cash flow that funds the dividend and buybacks, and still-positive share gains are a real margin of safety for a business the market has already demoted to a mature cash cow. The burden of proof is on the bear to show the stall is worse than the price assumes — worse than flat — because flat is what 10 times already pays for.

The ruling flips on one dated observation. At the October 6 fiscal second-quarter report, watch beer depletions against last quarter's minus 0.3%. If the rate improves toward positive — or even holds — the value case strengthens and the multiple can re-rate. If depletions deteriorate meaningfully, or if management pulls comparable EPS guidance below the $11.20 floor, the bear's structural story gains the evidence it has lacked, and the cheapness is exposed as a value trap rather than a discount. That single number, in three weeks, decides which side had the odds all along.